Amplitude Surgical

Back to previous page

Identification

AMPLI
Name: Amplitude Surgical
Market: Euronext Paris
Capitalization compartment: Compartment B
Subsector: Medical Supplies
Isin code: FR0012789667
Symbol: AMPLI

Operation

IPO Date: 26/06/2015
Issue type: Initial Public offering
Price range: Narrowed Indicative Price Range EUR 5.00 - 6.00

Company Profile

Loading... Please wait.

News

Date Title
01 Jul 2015 Amplitude Surgical lists on Euronext Paris expand

Raises €100 million, market capitalisation €235 million

Paris – 30 June  2015– EnterNext, the Euronext subsidiary dedicated to promoting and growing the market for SMEs[1],today celebrated the listing of Amplitude Surgical, a leading French player on the global surgical technology market for lower-limb orthopedics, on 26 June 2015. Amplitude Surgical is listed on Euronext Paris in Compartiment B.

Founded in 1997 in Valence, France, Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main disorders affecting the hip, knee and extremities, and notably foot and ankle surgery.The Group also provides innovative services that add significant value to its product range, such as the AMPLIVISION® computer-assisted surgical navigation system, the i.M.A.G.E® single-use made-to-measure instrument system and the E.T.O.I.L.E® technology platform for anterior approaches resulting in less-invasive surgery.

Amplitude Surgical (ticker code: AMPLI) was listed through the admission to trading of the 46,929,852 shares making up its equity on 26 June 2015including 20,000,000new shares issued under a Global Offering[2].

The admission and issue price of ABIVAX shares was set at €5 per share. Market capitalisation was €234,649,260 million on the day of listing, and the transaction raised a total of €100million.

Olivier Jallabert, Chairman and CEO of Amplitude Surgical, said:“I am delighted with our successful listing on Euronext, which has expended the steadily growing compartment dedicated to healthcare. This is a key stage in pursuing our company’s international drive, both for the deploymnet of our commercial strategy and for changes in our capital structure. I would like to extend warm thanks to the shareholders that have joined us on this occasion.”

Eric Forest, CEO of EnterNext, said: “We are delighted to welcome Amplitude Surgical to listing on Euronext. EnterNext works with many medtech companies that turn to financial markets to raise the capital they need to accelerate their growth. Listing will bring Amplitude Surgical the resources it needs to step up deployment of its strategy, in particular on international markets.”

To celebrate listing, Olivier Jallabert rang the bell closing trading on Euronext markets. He was accompanied by Amplitude Surgical’s management, advisers and the EnterNext team.



[1]Small and medium-size companies
[2]
The Global Offering was made up of a Public Offering that included an Open Price Public Offering and a Global Placement with institutional investors in France and other countries

 

30 Jun 2015 IPO Amplitude Surgical expand

EnterNext welcomes Amplitude Surgical on Euronext in Paris

Olivier Jallabert, CEO of Amplitude Surgical, rings the closing bell.

Amplitude Surgical specializes in the design, manufacture and marketing of implants dedicated to surgery of knee and hip. In addition, the group offers orthopedic instruments, technical support and logistics services.